-+ 0.00%
-+ 0.00%
-+ 0.00%

BioMarin shareholders approved 7,650,000-share increase to 2017 equity plan at annual meeting

PUBT·06/04/2026 20:25:26
Listen to the news
BioMarin shareholders approved 7,650,000-share increase to 2017 equity plan at annual meeting
  • BioMarin held its annual shareholder meeting on June 2, 2026.
  • Shareholders adopted an amendment to the 2017 Equity Incentive Plan, adding 7,650,000 shares reserved for issuance; it took effect immediately.
  • Shareholders ratified KPMG as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioMarin Pharmaceutical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-040812), on June 04, 2026, and is solely responsible for the information contained therein.